黄北鲲,邓丽侠,李东泽,曾智

• 1:四川大学华西医院心脏内科

摘要(Abstract)：

<正>目前,我国先天性心脏病(先心病)的发病率为7‰~8‰,新生儿每年患病约有12万~15万~[1]。过去开胸手术是治疗该病的唯一方法,随着介入治疗学科的发展,该技术在临床中逐渐普及,成为不同种类先心病的常用治疗方式。目前先心病介入治疗的主要手术有房间隔缺损封堵术、卵圆孔未闭封堵术、室间隔缺损封堵术以及动脉导管未闭封堵术,总体临床效果较满意。术后血栓形成发生率不高,但有

关键词(KeyWords)： 先天性心脏病;封堵器;血栓

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 黄北鲲,邓丽侠,李东泽,曾智

参考文献(References)：

• [1]周爱卿,蒋世良.先天性心脏病经导管介入治疗指南.中华儿科杂志,2004,42(3):234-239.
• [2]Kuhn MA,Latson LA,Cheatham JP,et al.Biological response to Bard Clamshell Septal Occluders in the canine heart.Circulation,1996,93(7):1459-1463.
• [3]Foth R,Quentin T,Michel-Behnke I,et al.Immunohistochemical characterization of neotissues and tissue reactions to septal defectocclusion devices.Circ Cardiovasc Interv,2009,2(2):90-96.
• [4]Rodés-Cabau J,Palacios A,Palacio C,et al.Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects.Int J Cardiol,2005,98(1):107-112.
• [5]Krumsdorf U,Ostermayer S,Billinger K,et al.Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1 000 consecutive patients.J Am Coll Cardiol,2004,43(2):302-309.
• [6]Anzai H,Child J,Natterson B,et al.Incidence of thrombus formation on the Cardio SEAL and the Amplatzer interatrial closure devices.Am J Cardiol,2004,93(4):426-431.
• [7]Sherman JM,Hagler DJ,Cetta F.Thrombosis after septal closure device placement:a review of the current literature.Catheter Cardiovasc Interv,2004,(63):486-489.
• [8]Lambert V,Losay J,Piot JD,et al.Late complications of percutaneous closure of atrial septal defects with the Sideris occluder.Arch Mal Coeur Vaiss,1997,90(2):245-251.
• [9]中国医师协会心血管内科分会先心病工作委员会.常见先天性心脏病介入治疗中国专家共识一、房间隔缺损治疗.介入放射学杂志,2011,20(1):3-9.
• [10]刘慧慧,李文,曹勇军,等.卵圆孔未闭与偏头痛性脑梗死.中华脑血管病杂志:电子版,2011,5(6):2-5.
• [11]Aytemir K,Oto A,zkutlu S,et al.Transcatheter interatrial septal defect closure in a large cohort:midterm follow-up results.Congenit Heart Dis,2013,8(5):418-427.
• [12]Rigatelli G,Dell'Avvocata F,Cardaioli P,et al.Five-year follow-up of intracardiac echocardiography-assisted transcatheter closure of complex ostium secundum atrial septal defect.Congenit Heart Dis,2012,7(2):103-110.
• [13]Raghu A,Kawalsky D,Feldman M.Embolic stroke due to a left atrial thrombus two years after placement of an atrial septal defect closure device.Am J Cardiol,2006,98(9):1294-1296.
• [14]Tárnok A,Bocsi J,Osmancik P,et al.Cardiac troponin I release after transcatheter atrial septal defect closure depends on occluder size but not on patient's age.Heart,2005,91(2):219-222.
• [15]Butera G,Carminati M,Chessa M,et al.Transcatheter closure of perimembranous ventricular septal defects:early and long-term results.J Am Coll Cardiol,2007,50(12):1189-1195.
• [16]李田昌,胡大一,边红,等.膜周部室间隔缺损介入治疗的中远期疗效.中华医学杂志,2005,85(40):2846-2849.
• [17]Carminati M,Butera G,Chessa M,et al.Transcatheter closure of congenital ventricular septal defects:results of the European Registry.Eur Heart J,2007,28(19):2361-2368.
• [18]刘洋,张刚成,尚小珂,等.动脉导管未闭1251例经导管介入治疗并发症分析.中国介入心脏病学杂志,2014,22(12):796-800.
• [19]de Moor M,Abbag F,al Fadley F,et al.Thrombosis on the Rashkind double umbrella device:A complication of PDA occlusion.Cathet Cardiovasc Diagn,1996,38(2):186-188.
• [20]Collins N,Mehta R,Benson L,et al.Percutaneous coronary artery fistula closurein adults:Technical and procedural aspects.Catheter Cardiovasc Interv,2007,69(6):872-880.
• [21]Jama A,Barsoum M,Bjarnason H,et al.Percutaneous closure of congenital coronary artery fistulae:results and angiographic follow-up.JACC Cardiovasc Interv,2011,4(7):814-821.
• [22]Valente AM,Lock JE,Gauvreau K,et al.Predictors of longterm adverse outcomes in patients with congenital coronary artery fistulae.Circ Cardiovasc Interv,2010,3(2):134-139.
• [23]Fang ZF,Tang L,Zhou SH.Ischemic stroke caused by paradoxical embolism after an unsuccessful transcatheter atrial septal defect closure procedure:a word of caution.Pediatr Cardiol,2012,33(2):366-369.
• [24]Eren NK,Akyildiz ZI,Acet H,et al.Thrombus formation on the delivery sheath during transcatheter atrial septal defect closure.Tex Heart Inst J,2009,36(36):624-625.
• [25]Divchev D,Schaefer A,Fuchs M,et al.Thrombus formation on an atrial septal defect closure device:A case report and review of the literature.Eur J Echocardiogr,2007,8(1):53-56.
• [26]曾晓春,伍伟锋,黄凯,等.房间隔缺损封堵术患者血浆F1+2水平及血小板CD62P、CD41a表达的变化.临床心血管病杂志,2009,25(10):769-772.
• [27]张志宏,覃军,黄岚,等.房间隔缺损封堵术后不同抗凝方案安全性及疗效分析.中国介入心脏病学杂志,2010,18(5):247-251.
• [28]Brandt RR,Neumann T,Neuzner J,et al.Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device:No evidence for thrombus deposition with antiplatelet agents.J Am Soc Echocardiogr,2002,15(10 Pt 1):1094-1098.
• [29]Sievert H,Babic UU,Hausdorf G,et al.Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device(a multi-institutional european trial).Am J Cardiol,1998,82(11):1405-1413.
• [30]Zhou Y,Chen F,Huang X,et al.A new coated nitinol occluder for transcatheter closure of ventricular septal defects in a canine model.Biomed Res Int,2013,2013(12):491-512.
• [31]周陵,陈绍良,叶飞,等.经导管法封堵冠状动脉瘘临床分析.临床心血管病杂志,2006,22(2):77-79.
• [32]肖云彬,陈智,黄希勇,等.不同类型先天性冠状动脉瘘介入治疗随访研究.中国当代儿科杂志,2015,17(4):384-389.
• [33]Yorgun H,Canpolat U,Kaya EB,et al.Thrombus formation during percutaneous closure of an atrial septal defect with an Amplatzer septal occluder.Tex Heart Inst J,2010,38(4):427-430.
• [34]Sherman JM,Hagler DJ,Cetta F.Thrombosis after septal closure device placement:A review of the current literature.Catheter Cardiovasc Interv,2004,63(4):486-489.